TerrAscend Stock Pops as it Raises Guidance for 2023 Revenue

The company expects 2023 net revenue of at least $317 million.

TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) continues to crush it as the company is one of the few cannabis operators raising its revenue guidance. During its investor day at the Toronto Stock Exchange, TerrAscend updated its expectations for the year. The company’s stock jumped by 4% on the news and was lately selling at $1.91.

TerrAscend raised its 2023 guidance for net revenue and adjusted EBITDA from continuing operations to at least $317 million and $63 million, respectively, representing year-over-year growth of 28% in net revenue and 62% in adjusted EBITDA from continuing operations. The company’s previous guidance was at least $305 million and $58 million, respectively.

“We have good visibility and confidence in the remainder of the year as evidenced by the increase in our full-year guidance,” stated Jason Wild, executive chairman. “We expect to drive industry-leading revenue growth, continued improvement across all P&L metrics, and positive free cash flow in the second half of the year.”

In addition to the revenue adjustments, the company expects gross margin to exceed 50% and free cash flow from continuing operations to be positive for the second half of the year.

State Updates

Earlier this week, PA Homepage reported that Chantelle Elsner, the acting president of Terrascend Northeast, spoke about the medical Pennsylvania market.

“So as we see the medical market over this 2023 time frame, we expect it to exceed $1 billion in the Pennsylvania market for 2023,” Elsner said. “We expect about a 40% lift when hopefully the state converts to adult use.”

TerrAscend noted in its investor presentation that it has become the No. 2 operator in New Jersey and has the opportunity to add seven additional retail doors under The Apothecarium banner, which will drive additional scale and profitability to its retail operations in the state.

The company hit its cap of four stores in Maryland, but said that wholesale demand is growing.

In Michigan, the company said it is on track for a positive EBITDA by the end of 2023. It is evaluating multiple opportunities to expand its retail footprint due to Michigan’s unlimited license structure.


Debra Borchardt

Debra Borchardt is the Co-Founder, and Executive Editor of GMR. She has covered the cannabis industry for several years at Forbes, Seeking Alpha and TheStreet. Prior to becoming a financial journalist, Debra was a Vice President at Bear Stearns where she held a Series 7 and Registered Investment Advisor license. Debra has a Master's degree in Business Journalism from New York University.

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.